NAVANDEEP MALHI: Open Payments
NPI 1740843564 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 64 payments from 19 companies in 2025. Trend: 2023 $980 · 2024 $1,325 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $264 |
| Teva Pharmaceuticals USA, Inc. | 10 | $227 |
| Biogen, Inc. | 8 | $139 |
| TG Therapeutics, Inc. | 4 | $103 |
| ARGENX US, INC. | 4 | $92 |
| Eisai Inc. | 4 | $88 |
| UCB, Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $69 |
| JAZZ PHARMACEUTICALS INC. | 2 | $59 |
| Amgen Inc. | 3 | $55 |
Products named: AUSTEDO XR, QULIPTA, TYSABRI, BRIUMVI, VYVGART HYTRULO, UBRELVY, Leqembi, AMYVID.
Industry payments across PA — which companies pay providers there.
